Meeting
2019 ASCO Annual Meeting
Prediction of occult axillary metastases in treatment-naïve patients with breast cancer: A transSENTINA analysis.
Authors
Cornelia Kolberg-Liedtke
Charité - Universitätsmedizin Berlin, Berlin, Germany
Cornelia Kolberg-Liedtke , Hans-Christian Kolberg , Ingo Bauerfeind , Tanja N. Fehm , Barbara Fleige , Annette Lebeau , Lukas Schwentner , Annette Staebler , Sibylle Loibl , Michael Untch , Thorsten Kühn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 37, 2019 (suppl; abstr 566)
DOI
10.1200/JCO.2019.37.15_suppl.566
Abstract #
566
Poster Bd #
58
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Association between tumor biology and occult lymph node metastases before and after primary neoadjuvant therapy (NAT) for patients with early breast cancer.
First Author: Hans-Christian Kolberg
Poster
2019 ASCO Annual Meeting
Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis.
First Author: Marissa K. Srour
Poster
2014 ASCO Annual Meeting
Long-term follow up (FU) of patients with durable complete response (DCR) after chemotherapy (CT) and HER2-targeting systemic therapy (HER2-Tx) for HER2+ metastatic breast cancer (MBC).
First Author: Giuseppe Gullo
Poster
2024 ASCO Breakthrough
Differences in the expression heterogeneity of ADC-related markers between primary tumors and metastatic lymph nodes in advanced urothelial cancers.
First Author: Xingliang Tan